Targeting tumor ‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)

Int J Oncol. 2024 Jun;64(6):60. doi: 10.3892/ijo.2024.5648. Epub 2024 May 2.ABSTRACTTumor‑associated macrophages (TAMs) are essential components of the tumor microenvironment (TME) and display phenotypic heterogeneity and plasticity associated with the stimulation of bioactive molecules within the TME. TAMs predominantly exhibit tumor‑promoting phenotypes involved in tumor progression, such as tumor angiogenesis, metastasis, immunosuppression and resistance to therapies. In addition, TAMs have the potential to regulate the cytotoxic elimination and phagocytosis of cancer cells and interact with other immune cells to engage in the innate and adaptive immune systems. In this context, targeting TAMs has been a popular area of research in cancer therapy, and a comprehensive understanding of the complex role of TAMs in tumor progression and exploration of macrophage‑based therapeutic approaches are essential for future therapeutics against cancers. The present review provided a comprehensive and updated overview of the function of TAMs in tumor progression, summarized recent advances in TAM‑targeting therapeutic strategies and discussed the obstacles and perspectives of TAM‑targeting therapies for cancers.PMID:38695252 | DOI:10.3892/ijo.2024.5648
Source: International Journal of Oncology - Category: Cancer & Oncology Authors: Source Type: research